Warning letters, 483s, Recalls, Import Alerts, Audit observations
CDSCO has published an update on the Spurious and Misbranded drugs in September 2024. Medicinal
CDSCO has published alert of list of drugs Not of Standard Quality (NSQ) identified during
The European Commission (EC) revoked the conditional marketing authorization (CMA) of Advanz Pharma’s Ocaliva (obeticholic
CDSCO has published a drug alert regarding voluntary recall of Tisseel Lyo Fibrin Sealant VHS/D
CDSCO has published the NSQ (Not of Standard Quality) alert for July 2024. The list
CDSCO has published list of drugs which were found to be not of standard quality
CDSCO has issued spurious drug alert for five medicinal products. The spurious drug alert includes
WHO has issued an alert on falsified Propylene glycol bearing name of Dow detected in
